PraeDicare's Incubator/Accelerator Round

PraeDicare raised a round of funding on January 15, 2018. Investors include JLabs.

PraeDiCare provides an in vitro quantitative pharmacology platform that reduces drug development costs by more accurately predicting clinical treatment efficacy and safety in the drug discovery settin…

Articles about PraeDicare's Incubator/Accelerator Round: